Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

40.22
Delayed Data
As of 4:14pm ET
 -1.09 / -2.64%
Today’s Change
37.59
Today|||52-Week Range
55.51
-25.61%
Year-to-Date
Mylan (MYL) CEO Bresch Will Have to Explain EpiPen Profits, WSJ's Baker Says
Sep 27 / TheStreet.com - Paid Partner Content
'Cheap Shot' to Bring Her Mother Into EpiPen Controversy, Mylan (MYL) CEO Says
Sep 21 / TheStreet.com - Paid Partner Content
Frontrunning: September 27
Sep 27 / Investing Channel - Paid Partner Content
Mylan's First Date With Congress Proves 'Painful'
Sep 21 / TheStreet.com - Paid Partner Content
"Hillary Rally" Fizzles As DB Hits New Record Low; Volkswagen Slammed; Oil Slides On ...
Sep 27 / Investing Channel - Paid Partner Content
Mylan (MYL) CEO Bresch Grilled by Rep. Cummings at Hearing
Sep 21 / TheStreet.com - Paid Partner Content
Here's How the Markets Could React to the First Clinton-Trump Presidential Debate
Sep 26 / TheStreet.com - Paid Partner Content
Mylan CEO Explains To Congress Why EpiPen Prices Rose 550% in 9 Years - Live Feed
Sep 21 / Investing Channel - Paid Partner Content
Mylan (MYL) CEO's Testimony Underestimated EpiPen Profits
Sep 26 / Zacks.com - Paid Partner Content
EpiPen Controversy: Mylan's Tough Week Just Keeps Getting Grimmer
Sep 21 / TheStreet.com - Paid Partner Content
Mylan (MYL) Accounted for a U.S. Tax Rate in the Profitability of the EpiPen.
Sep 26 / TheStreet.com - Paid Partner Content
Lawmakers say EpiPen hikes made Mylan executives 'filthy rich'
Sep 21 / CNNMoney.com
Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says
Sep 26 / TheStreet.com - Paid Partner Content
Mylan (MYL) CEO Faces Hearing After Wells Fargo CEO Blasted by Senate
Sep 21 / TheStreet.com - Paid Partner Content
Trending Tickers: TWTR, VRX, ENDP, RIG
Sep 26 / TheStreet.com - Paid Partner Content
Morning Movers: MYL, XOM, MSFT, GIS, CLVS
Sep 21 / TheStreet.com - Paid Partner Content
Andrew Left Says Trump and Clinton Agree on Just One Thing
Sep 26 / TheStreet.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Wednesday
Sep 21 / TheStreet.com - Paid Partner Content
Mylan Admits EpiPen Profits 60% Higher Than It Told Congress, Stock Slips
Sep 26 / Investing Channel - Paid Partner Content
Japan lifts markets; Fed up next; oil prices rise
Sep 21 / CNNMoney.com
Mylan (MYL) Stock Declines, Clarifies EpiPen Profit Figures Given to Congress
Sep 26 / TheStreet.com - Paid Partner Content
Mylan CEO's Mother Pushed Schools to Buy EpiPens
Sep 20 / Zacks.com - Paid Partner Content
Week in Review: Fed Holds Focus in Wild Week
Sep 23 / TheStreet.com - Paid Partner Content
CEO says Mylan isn't getting rich off EpiPen
Sep 20 / CNNMoney.com
Next Drug Price Scandal Could be Cost of Naloxone
Sep 23 / TheStreet.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
The Zacks Friday Finish Line Highlights: IPOs, Netflix, Comcast, Wells Fargo, Mylan
Sep 23 / Zacks.com - Paid Partner Content
Forget Novavax, Buy These 4 Biotech Stocks Instead
Sep 16 / Zacks.com - Paid Partner Content
5 Most Shocking Congressional Testimonies by CEOs
Sep 23 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Mylan, ANI Pharmaceuticals, Cambrex, PDL BioPharma...
Sep 14 / Zacks.com - Paid Partner Content
Wells Fargo and Mylan: Corporate Devils or Unworthy Scapegoats?
Sep 23 / Zacks.com - Paid Partner Content
Mylan agrees to give EpiPen documents to Congress
Sep 12 / CNNMoney.com
CEO Isn't All That's Under Pressure at Mylan
Sep 23 / TheStreet.com - Paid Partner Content
EpiPen maker still has explaining to do
Sep 09 / CNNMoney.com
3 Options Terms Every Retail Investor Should Know
Sep 22 / TheStreet.com - Paid Partner Content
'Middlemen' under the spotlight in EpiPen furore
Sep 09 / FT.com - Paid Partner Content
Mylan (MYL) Facing 'Huge' Financial Impact with Generic EpiPen
Sep 22 / TheStreet.com - Paid Partner Content
CEO of Botox maker vows to limit price hikes
Sep 07 / CNNMoney.com
Here's What Pissed-Off Congressmen Said to Mylan's CEO
Sep 22 / Zacks.com - Paid Partner Content
Clinton promises panel to vet drug price rises
Sep 02 / FT.com - Paid Partner Content
More Squawk From Jim Cramer: Mylan (MYL) Should Have Immediately Cut EpiPen Price
Sep 22 / TheStreet.com - Paid Partner Content
EpiPen CEO could score $28 million payday thanks to price hikes
Aug 31 / CNNMoney.com
Mylan (MYL) CEO Bresch Not the Only One Benefiting from EpiPen Price Hike
Sep 22 / TheStreet.com - Paid Partner Content
I know who to thank for my trusted EpiPen and it is not Mylan
Aug 31 / FT.com - Paid Partner Content
Frontrunning: September 22
Sep 22 / Investing Channel - Paid Partner Content
How EpiPen came to symbolize corporate greed
Aug 29 / CNNMoney.com
Stock Futures Rise as Wall Street Finds Relief in a Patient Fed
Sep 22 / TheStreet.com - Paid Partner Content
Mylan to launch cut-price generic version of EpiPen
Aug 29 / FT.com - Paid Partner Content
Mylan chief comes under fire over cost of EpiPen
Sep 21 / FT.com - Paid Partner Content
Generic EpiPen coming for $300, as Mylan responds to outrage
Aug 29 / CNNMoney.com